Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page. This reflects a maintenance update to the record history rather than changes to the study data.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoChange Detected- The history now includes a new page revision entry for v3.6.4, replacing v3.6.3. This indicates an update to the page's record.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedNew revision number v3.6.3 is now shown, replacing the previous v3.6.2. This indicates the study record has been updated to a newer version, reflecting changes since the prior revision.SummaryDifference0.1%

- Check47 days agoChange DetectedThe revision history now shows a new revision entry (v3.6.2). This update reflects an update to the page's versioning record rather than substantive content changes.SummaryDifference0.1%

- Check54 days agoChange DetectedA new References section has been added to the study record page, listing sources cited in the record to support the information presented.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision v3.6.0 was added and the study now shows no longer looking for participants, replacing the previous revision v3.5.5.SummaryDifference0.3%

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.